查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1807675

液态生物检体的全球市场:市场规模·占有率·趋势，产业分析 (各样品类型·生物标记·各技术·各用途·各最终用途·各地区)，2025～2034年的市场预测

Liquid Biopsy Market Size, Share, Trends, Industry Analysis Report By Sample Type (Blood Sample, Others), By Biomarker, By Technology, By Application, By End Use, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的一项新研究，预计到 2034 年，全球液体活检市场规模将达到 365.9 亿美元。本研究报告深入分析了当前的市场动态，并分析了未来的市场成长。

液体活检是一种先进的非侵入性诊断测试，可分析血液或尿液等简单液体样本中的生物标记。与需要外科手术的传统组织活检不同，这种方法能够提供更安全、更方便的疾病资讯。此方法专注于检测肿瘤脱落到血液中的微小 DNA、RNA 和蛋白质片段，从而深入了解肿瘤的基因组成及其随时间推移的进展。这使其成为癌症诊断、监测和治疗计划的有力工具。

随着全球癌症患者数量的增加，人们对侵入性更小、更精准的诊断工具的需求日益增长，这推动了这一市场的发展。个人化医疗的推动也发挥着重要作用，因为液体活检可以帮助识别特定的基因突变，从而为患者的治疗计划提供参考。随着技术日益成熟和经济实惠，液体活检的应用范围正从癌症活检扩展到生殖健康和疾病监测等领域，进一步推动了液体活检市场的成长。

液体切片市场：分析概述

按样本类型划分，血液样本在2024年占了最大的市场占有率。

按生物标记划分，循环肿瘤DNA (ctDNA) 因其高灵敏度和特异性而占了最大的市场占有率。

按技术划分，新一代定序 (NGS) 因其能够同时分析多个基因而占了最大的市场占有率。它也常用于晚期癌症诊断和个人化治疗计划。

依应用划分，肿瘤学领域占最大占有率。液体切片在肿瘤学领域用途广泛，包括早期诊断、选择最有效的个人化治疗方案以及监测患者对治疗的反应。

依最终用途划分，医院和实验室占最大占有率。这是因为它们在癌症诊断和治疗中广泛应用，并且拥有必要的基础设施。

按地区划分，预计北美将在2024年占最大的市场占有率，这得益于其完善的医疗保健体系和先进的诊断技术。亚太地区是成长最快的区域市场之一。不断增长的医疗保健支出和对医疗保健基础设施的日益关注正在推动该地区的市场成长。

液体切片市场的主要参与者包括 F. Hoffmann-La Roche、Illumina, Inc.、Guardant Health、Bio-Rad Laboratories、Thermo Fisher Scientific、Natera, Inc.、Exact Sciences、Adaptive Biotechnologies、Myriad Genetics 和 NeoGenomics Laboratories。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球液态生物检体市场洞察

  • 频率概览
  • 液体切片市场动态
    • 驱动因素与机遇
      • 全球癌症发生率上升
      • 个人化医疗的进展
    • 限制因素与课题
      • 早期癌症检测的敏感度限制
  • PESTEL分析
  • 液态生物检体市场趋势
  • 价值链分析
  • COVID-19影响分析

第5章 全球液态生物检体市场:各样品类型

  • 主要的分析结果
  • 简介
  • 血液样品
  • 其他

第6章 全球液态生物检体市场:生物标记

  • 主要的分析结果
  • 简介
  • 循环肿瘤细胞(CTC)
  • 循环肿瘤DNA(ctDNA)
  • 细胞外小胞(EV)
  • 其他

第7章 全球液态生物检体市场:各技术

  • 主要的分析结果
  • 简介
  • 复数遗传基因并列分析(NGS)
  • 单一遗传基因分析(PCR微阵列)

第8章 全球液态生物检体市场:各用途

  • 主要的分析结果
  • 简介
  • 癌症
  • 生殖健康
  • 其他

第9章 全球液态生物检体市场:各最终用途

  • 主要的分析结果
  • 简介
  • 医院·检验室
  • 专门诊所
  • 学术研究中心
  • 其他

第10章 全球液态生物检体市场:各地区

  • 主要的分析结果
  • 简介
    • 液态生物检体市场分析:各地区 (2020～2034年)
  • 北美
    • 北美:各样品类型(2020～2034年)
    • 北美:各生物标记(2020～2034年)
    • 北美:各技术(2020～2034年)
    • 北美:各用途(2020～2034年)
    • 北美:各最终用途(2020～2034年)
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各样品类型(2020～2034年)
    • 欧洲:各生物标记(2020～2034年)
    • 欧洲:各技术(2020～2034年)
    • 欧洲:各用途(2020～2034年)
    • 欧洲:各最终用途(2020～2034年)
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各样品类型(2020～2034年)
    • 亚太地区:各生物标记(2020～2034年)
    • 亚太地区:各技术(2020～2034年)
    • 亚太地区:各用途(2020～2034年)
    • 亚太地区:各最终用途(2020～2034年)
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各样品类型(2020～2034年)
    • 中东·非洲:各生物标记(2020～2034年)
    • 中东·非洲:各技术(2020～2034年)
    • 中东·非洲:各用途(2020～2034年)
    • 中东·非洲:各最终用途(2020～2034年)
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东·非洲
  • 南美
    • 南美:各样品类型(2020～2034年)
    • 南美:各生物标记(2020～2034年)
    • 南美:各技术(2020～2034年)
    • 南美:各用途(2020～2034年)
    • 南美:各最终用途(2020～2034年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第11章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第12章 企业简介

  • Adaptive Biotechnologies Corporation
  • Bio-Rad Laboratories, Inc.
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • NeoGenomics Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
Product Code: PM1521

The global liquid biopsy market size is expected to reach USD 36.59 billion by 2034, according to a new study by Polaris Market Research. The report "Liquid Biopsy Market Size, Share, Trends, Industry Analysis Report By Sample Type (Blood Sample, Others), By Biomarker, By Technology, By Application, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

A liquid biopsy is an advanced, noninvasive diagnostic test that analyzes biological markers from a simple fluid sample, such as blood or urine. Unlike a traditional tissue biopsy, which requires a surgical procedure, this method allows for a safer and more convenient way to gather information about a disease. It primarily focuses on detecting tiny fragments of DNA, RNA, and proteins shed by tumors into the bloodstream, offering doctors a detailed look at a tumor's genetic makeup and progression over time. This makes it an especially powerful tool for cancer diagnosis, monitoring, and treatment planning.

The market is driven by the growing need for less invasive and more accurate diagnostic tools, especially with the rising number of cancer cases worldwide. The push for personalized medicine has also been a major influence, as liquid biopsies can help identify specific genetic mutations that inform a patient's treatment plan. As technologies become more refined and affordable, the application of liquid biopsies is expanding beyond cancer biopsy into areas such as reproductive health and disease monitoring, further fueling the liquid biopsy market expansion.

Liquid Biopsy Market Report Highlights

Based on sample type, the blood sample segment held the largest share in 2024, owing to its convenience and the wide range of biomarkers it provides.

In terms of biomarker, the circulating tumor DNA (ctDNA) segment held the largest share because of its high sensitivity and specificity.

By technology, the multi-gene parallel analysis (NGS) segment held the largest share due to its ability to analyze multiple genes at once. It is also commonly used for advanced cancer diagnostics and personalized treatment planning.

By application, the cancer segment held the largest share. Liquid biopsies are highly valuable in oncology for a wide range of uses, including initial diagnosis, selecting the most effective personalized therapies, and monitoring a patient's response to treatment..

By end use, the hospitals and laboratories segment held the largest share because they are widely utilized for cancer diagnosis and treatment, and have the necessary infrastructure.

By region, North America held the largest share in 2024 in the market due to its well-established healthcare system and presence of advanced diagnostics. Asia Pacific is one of the fastest-growing regional markets. Increasing healthcare spending and a growing focus on improving medical infrastructure are propelling the market growth in the region.

A few key players in the liquid biopsy market include F. Hoffmann-La Roche Ltd; Illumina, Inc.; Guardant Health, Inc.; Bio-Rad Laboratories, Inc.; Thermo Fisher Scientific, Inc.; Natera, Inc.; Exact Sciences Corporation; Adaptive Biotechnologies Corporation; Myriad Genetics, Inc.; and NeoGenomics Laboratories, Inc.

Polaris Market Research has segmented the liquid biopsy market report based on sample type, biomarker, technology, application, end use, and region:

By Sample Type Outlook (Revenue - USD Billion, 2020-2034)

Blood Sample

Others

By Biomarker Outlook (Revenue - USD Billion, 2020-2034)

Circulating Tumor Cells (CTCs)

Circulating Tumor DNA (ctDNA)

Extracellular Vehicles (EVs)

Others

By Technology Outlook (Revenue - USD Billion, 2020-2034)

Multi-gene parallel Analysis (NGS)

Single Gene Analysis (PCR Microarrays)

By Application Outlook (Revenue - USD Billion, 2020-2034)

Cancer

Reproductive Health

Others

By End Use Outlook (Revenue - USD Billion, 2020-2034)

Hospitals and Laboratories

Specialty Clinics

Academic and Research Centers

Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Liquid Biopsy Market Insights

  • 4.1. Liquid Biopsy Market - Frequency Snapshot
  • 4.2. Liquid Biopsy Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Global Cancer Incidence
      • 4.2.1.2. Advancements in Personalized Medicine
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Limited sensitivity in early-stage cancer detection
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Liquid Biopsy Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Liquid Biopsy Market, by Sample Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • 5.3. Blood Sample
    • 5.3.1. Global Liquid Biopsy Market, Blood Sample, by Region, 2020-2034 (USD Billion)
  • 5.4. Others
    • 5.4.1. Global Liquid Biopsy Market, Others, by Region, 2020-2034 (USD Billion)

6. Global Liquid Biopsy Market, by Biomarker

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • 6.3. Circulating Tumor Cells (CTCs)
    • 6.3.1. Global Liquid Biopsy Market, by Circulating Tumor Cells (CTCs), by Region, 2020-2034 (USD Billion)
  • 6.4. Circulating Tumor DNA (ctDNA)
    • 6.4.1. Global Liquid Biopsy Market, by Circulating Tumor DNA (ctDNA), by Region, 2020-2034 (USD Billion)
  • 6.5. Extracellular Vehicles (EVs)
    • 6.5.1. Global Liquid Biopsy Market, by Extracellular Vehicles (EVs), by Region, 2020-2034 (USD Billion)
  • 6.6. Others
    • 6.6.1. Global Liquid Biopsy Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Liquid Biopsy Market, by Technology

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • 7.3. Multi-gene parallel Analysis (NGS)
    • 7.3.1. Global Liquid Biopsy Market, by Multi-gene parallel Analysis (NGS), by Region, 2020-2034 (USD Billion)
  • 7.4. Single Gene Analysis (PCR Microarrays)
    • 7.4.1. Global Liquid Biopsy Market, by Single Gene Analysis (PCR Microarrays), by Region, 2020-2034 (USD Billion)

8. Global Liquid Biopsy Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • 8.3. Cancer
    • 8.3.1. Global Liquid Biopsy Market, by Cancer, by Region, 2020-2034 (USD Billion)
  • 8.4. Reproductive health
    • 8.4.1. Global Liquid Biopsy Market, by Reproductive health, by Region, 2020-2034 (USD Billion)
  • 8.5. Others
    • 8.5.1. Global Liquid Biopsy Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Liquid Biopsy Market, by End Use

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • 9.3. Hospitals and Laboratories
    • 9.3.1. Global Liquid Biopsy Market, by Hospitals and Laboratories, by Region, 2020-2034 (USD Billion)
  • 9.4. Specialty Clinics
    • 9.4.1. Global Liquid Biopsy Market, by Specialty Clinics, by Region, 2020-2034 (USD Billion)
  • 9.5. Academic and Research Centers
    • 9.5.1. Global Liquid Biopsy Market, by Academic and Research Centers, by Region, 2020-2034 (USD Billion)
  • 9.6. Others
    • 9.6.1. Global Liquid Biopsy Market, by Others, by Region, 2020-2034 (USD Billion)

10. Global Liquid Biopsy Market, by Geography

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Liquid Biopsy Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 10.3. Liquid Biopsy Market - North America
    • 10.3.1. North America: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
    • 10.3.2. North America: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
    • 10.3.3. North America: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
    • 10.3.4. North America: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
    • 10.3.5. North America: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
    • 10.3.6. North America: Sample Type
    • 10.3.7. Liquid Biopsy Market - U.S.
      • 10.3.7.1. U.S.: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
      • 10.3.7.2. U.S.: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
      • 10.3.7.3. U.S.: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
      • 10.3.7.4. U.S.: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
      • 10.3.7.5. U.S.: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
    • 10.3.8. Liquid Biopsy Market - Canada
      • 10.3.8.1. Canada: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
      • 10.3.8.2. Canada: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
      • 10.3.8.3. Canada: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
      • 10.3.8.4. Canada: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
      • 10.3.8.5. Canada: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • 10.4. Liquid Biopsy Market - Europe
    • 10.4.1. Europe: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
    • 10.4.2. Europe: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
    • 10.4.3. Europe: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
    • 10.4.4. Europe: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
    • 10.4.5. Europe: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
    • 10.4.6. Liquid Biopsy Market - UK
      • 10.4.6.1. UK: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
      • 10.4.6.2. UK: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
      • 10.4.6.3. UK: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
      • 10.4.6.4. UK: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
      • 10.4.6.5. UK: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
    • 10.4.7. Liquid Biopsy Market - France
      • 10.4.7.1. France: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
      • 10.4.7.2. France: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
      • 10.4.7.3. France: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
      • 10.4.7.4. France: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
      • 10.4.7.5. France: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
    • 10.4.8. Liquid Biopsy Market - Germany
      • 10.4.8.1. Germany: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
      • 10.4.8.2. Germany: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
      • 10.4.8.3. Germany: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
      • 10.4.8.4. Germany: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
      • 10.4.8.5. Germany: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
    • 10.4.9. Liquid Biopsy Market - Italy
      • 10.4.9.1. Italy: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
      • 10.4.9.2. Italy: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
      • 10.4.9.3. Italy: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
      • 10.4.9.4. Italy: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
      • 10.4.9.5. Italy: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
    • 10.4.10. Liquid Biopsy Market - Spain
      • 10.4.10.1. Spain: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
      • 10.4.10.2. Spain: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
      • 10.4.10.3. Spain: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
      • 10.4.10.4. Spain: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
      • 10.4.10.5. Spain: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
    • 10.4.11. Liquid Biopsy Market - Netherlands
      • 10.4.11.1. Netherlands: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
      • 10.4.11.2. Netherlands: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
      • 10.4.11.3. Netherlands: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
      • 10.4.11.4. Netherlands: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
      • 10.4.11.5. Netherlands: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
    • 10.4.12. Liquid Biopsy Market - Russia
      • 10.4.12.1. Russia: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
      • 10.4.12.2. Russia: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
      • 10.4.12.3. Russia: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
      • 10.4.12.4. Russia: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
      • 10.4.12.5. Russia: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
    • 10.4.13. Liquid Biopsy Market - Rest of Europe
      • 10.4.13.1. Rest of Europe: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
      • 10.4.13.2. Rest of Europe: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
      • 10.4.13.3. Rest of Europe: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
      • 10.4.13.4. Rest of Europe: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
      • 10.4.13.5. Rest of Europe: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • 10.5. Liquid Biopsy Market - Asia Pacific
    • 10.5.1. Asia Pacific: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
    • 10.5.2. Asia Pacific: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
    • 10.5.3. Asia Pacific: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
    • 10.5.4. Asia Pacific: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
    • 10.5.5. Asia Pacific: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
    • 10.5.6. Liquid Biopsy Market - China
      • 10.5.6.1. China: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
      • 10.5.6.2. China: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
      • 10.5.6.3. China: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
      • 10.5.6.4. China: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
      • 10.5.6.5. China: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
    • 10.5.7. Liquid Biopsy Market - India
      • 10.5.7.1. India: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
      • 10.5.7.2. India: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
      • 10.5.7.3. India: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
      • 10.5.7.4. India: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
      • 10.5.7.5. India: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
    • 10.5.8. Liquid Biopsy Market - Malaysia
      • 10.5.8.1. Malaysia: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
      • 10.5.8.2. Malaysia: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
      • 10.5.8.3. Malaysia: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
      • 10.5.8.4. Malaysia: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
      • 10.5.8.5. Malaysia: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
    • 10.5.9. Liquid Biopsy Market - Japan
      • 10.5.9.1. Japan: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
      • 10.5.9.2. Japan: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
      • 10.5.9.3. Japan: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
      • 10.5.9.4. Japan: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
      • 10.5.9.5. Japan: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
    • 10.5.10. Liquid Biopsy Market - Indonesia
      • 10.5.10.1. Indonesia: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
      • 10.5.10.2. Indonesia: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
      • 10.5.10.3. Indonesia: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
      • 10.5.10.4. Indonesia: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
      • 10.5.10.5. Indonesia: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
    • 10.5.11. Liquid Biopsy Market - South Korea
      • 10.5.11.1. South Korea: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
      • 10.5.11.2. South Korea: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
      • 10.5.11.3. South Korea: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
      • 10.5.11.4. South Korea: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
      • 10.5.11.5. South Korea: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
    • 10.5.12. Liquid Biopsy Market - Australia
      • 10.5.12.1. Australia: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
      • 10.5.12.2. Australia: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
      • 10.5.12.3. Australia: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
      • 10.5.12.4. Australia: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
      • 10.5.12.5. Australia: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
    • 10.5.13. Liquid Biopsy Market - Rest of Asia Pacific
      • 10.5.13.1. Rest of Asia Pacific: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
      • 10.5.13.2. Rest of Asia Pacific: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
      • 10.5.13.3. Rest of Asia Pacific: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
      • 10.5.13.4. Rest of Asia Pacific: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
      • 10.5.13.5. Rest of Asia Pacific: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • 10.6. Liquid Biopsy Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
    • 10.6.2. Middle East & Africa: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
    • 10.6.3. Middle East & Africa: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
    • 10.6.4. Middle East & Africa: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
    • 10.6.5. Middle East & Africa: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
    • 10.6.6. Liquid Biopsy Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
      • 10.6.6.2. Saudi Arabia: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
    • 10.6.7. Liquid Biopsy Market - UAE
      • 10.6.7.1. UAE: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
      • 10.6.7.2. UAE: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
      • 10.6.7.3. UAE: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
      • 10.6.7.4. UAE: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
      • 10.6.7.5. UAE: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
    • 10.6.8. Liquid Biopsy Market - Israel
      • 10.6.8.1. Israel: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
      • 10.6.8.2. Israel: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
      • 10.6.8.3. Israel: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
      • 10.6.8.4. Israel: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
      • 10.6.8.5. Israel: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
    • 10.6.9. Liquid Biopsy Market - South Africa
      • 10.6.9.1. South Africa: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
      • 10.6.9.2. South Africa: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
      • 10.6.9.3. South Africa: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
      • 10.6.9.4. South Africa: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
      • 10.6.9.5. South Africa: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
    • 10.6.10. Liquid Biopsy Market - Rest of Middle East & Africa
      • 10.6.10.1. Rest of Middle East & Africa: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
      • 10.6.10.2. Rest of Middle East & Africa: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
      • 10.6.10.3. Rest of Middle East & Africa: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
      • 10.6.10.4. Rest of Middle East & Africa: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
      • 10.6.10.5. Rest of Middle East & Africa: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • 10.7. Liquid Biopsy Market - Latin America
    • 10.7.1. Latin America: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
    • 10.7.2. Latin America: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
    • 10.7.3. Latin America: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
    • 10.7.4. Latin America: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
    • 10.7.5. Latin America: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
    • 10.7.6. Liquid Biopsy Market - Mexico
      • 10.7.6.1. Mexico: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
      • 10.7.6.2. Mexico: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
      • 10.7.6.3. Mexico: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
      • 10.7.6.4. Mexico: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
      • 10.7.6.5. Mexico: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
    • 10.7.7. Liquid Biopsy Market - Brazil
      • 10.7.7.1. Brazil: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
      • 10.7.7.2. Brazil: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
      • 10.7.7.3. Brazil: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
      • 10.7.7.4. Brazil: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
      • 10.7.7.5. Brazil: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
    • 10.7.8. Liquid Biopsy Market - Argentina
      • 10.7.8.1. Argentina: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
      • 10.7.8.2. Argentina: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
      • 10.7.8.3. Argentina: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
      • 10.7.8.4. Argentina: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
      • 10.7.8.5. Argentina: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
    • 10.7.9. Liquid Biopsy Market - Rest of Latin America
      • 10.7.9.1. Rest of Latin America: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
      • 10.7.9.2. Rest of Latin America: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
      • 10.7.9.3. Rest of Latin America: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
      • 10.7.9.4. Rest of Latin America: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
      • 10.7.9.5. Rest of Latin America: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. Adaptive Biotechnologies Corporation
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Bio-Rad Laboratories, Inc.
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Exact Sciences Corporation
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. F. Hoffmann-La Roche Ltd
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Guardant Health, Inc.
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Illumina, Inc.
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Myriad Genetics, Inc.
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Natera, Inc.
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. NeoGenomics Laboratories, Inc.
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Thermo Fisher Scientific, Inc.
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development

List of Tables:

  • Table 1 Global Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 2 Global Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 3 Global Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 4 Global Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 5 Global Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 6 North America: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 7 North America: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 8 North America: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 9 North America: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 10 North America: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 11 U.S.: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 12 U.S.: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 13 U.S.: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 14 U.S.: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 15 U.S.: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 16 Canada: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 17 Canada: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 18 Canada: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 19 Canada: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 20 Canada: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 21 Europe: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 22 Europe: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 23 Europe: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 24 Europe: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 25 Europe: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 26 UK: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 27 UK: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 28 UK: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 29 UK: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 30 UK: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 31 France: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 32 France: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 33 France: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 34 France: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 35 France: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 36 Germany: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 37 Germany: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 38 Germany: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 39 Germany: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 40 Germany: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 41 Italy: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 42 Italy: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 43 Italy: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 44 Italy: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 45 Italy: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 46 Spain: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 47 Spain: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 48 Spain: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 49 Spain: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 50 Spain: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 51 Netherlands: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 52 Netherlands: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 53 Netherlands: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 54 Netherlands: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 55 Netherlands: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 56 Russia: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 57 Russia: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 58 Russia: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 59 Russia: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 60 Russia: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 61 Rest of Europe: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 62 Rest of Europe: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 63 Rest of Europe: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 64 Rest of Europe: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 65 Rest of Europe: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 66 Asia Pacific: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 67 Asia Pacific: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 68 Asia Pacific: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 69 Asia Pacific: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 70 Asia Pacific: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 71 China: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 72 China: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 73 China: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 74 China: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 75 China: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 76 India: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 77 India: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 78 India: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 79 India: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 80 India: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 81 Malaysia: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 82 Malaysia: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 83 Malaysia: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 84 Malaysia: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 85 Malaysia: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 86 Japan: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 87 Japan: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 88 Japan: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 89 Japan: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 90 Japan: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 91 Indonesia: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 92 Indonesia: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 93 Indonesia: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 94 Indonesia: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 95 Indonesia: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 96 South Korea: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 97 South Korea: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 98 South Korea: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 99 South Korea: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 100 South Korea: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 101 Australia: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 102 Australia: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 103 Australia: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 104 Australia: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 105 Australia: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 106 Rest of Asia Pacific: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 107 Rest of Asia Pacific: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 108 Rest of Asia Pacific: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 109 Rest of Asia Pacific: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 110 Rest of Asia Pacific: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 111 Middle East & Africa: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 112 Middle East & Africa: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 113 Middle East & Africa: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 114 Middle East & Africa: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 115 Middle East & Africa: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 116 Saudi Arabia: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 117 Saudi Arabia: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 118 Saudi Arabia: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 119 Saudi Arabia: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 120 Saudi Arabia: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 121 UAE: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 122 UAE: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 123 UAE: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 124 UAE: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 125 UAE: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 126 Israel: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 127 Israel: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 128 Israel: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 129 Israel: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 130 Israel: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 131 South Africa: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 132 South Africa: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 133 South Africa: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 134 South Africa: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 135 South Africa: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 136 Rest of Middle East & Africa: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 137 Rest of Middle East & Africa: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 138 Rest of Middle East & Africa: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 139 Rest of Middle East & Africa: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 140 Rest of Middle East & Africa: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 141 Latin America: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 142 Latin America: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 143 Latin America: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 144 Latin America: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 145 Latin America: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 146 Mexico: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 147 Mexico: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 148 Mexico: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 149 Mexico: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 150 Mexico: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 151 Brazil: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 152 Brazil: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 153 Brazil: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 154 Brazil: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 155 Brazil: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 156 Argentina: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 157 Argentina: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 158 Argentina: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 159 Argentina: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 160 Argentina: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
  • Table 161 Rest of Latin America: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
  • Table 162 Rest of Latin America: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 163 Rest of Latin America: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
  • Table 164 Rest of Latin America: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
  • Table 165 Rest of Latin America: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Liquid Biopsy Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Sample Type
  • Figure 7. Global Liquid Biopsy Market, by Sample Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Biomarker
  • Figure 9. Global Liquid Biopsy Market, by Biomarker, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Technology
  • Figure 11. Global Liquid Biopsy Market, by Technology, 2024 & 2034 (USD Billion)
  • Figure 12. Market by Application
  • Figure 13. Global Liquid Biopsy Market, by Application, 2024 & 2034 (USD Billion)
  • Figure 14. Market by End Use
  • Figure 15. Global Liquid Biopsy Market, by End Use, 2024 & 2034 (USD Billion)